Concorde Asset Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $268K | Sell |
2,537
-42
| -2% | -$4.44K | 0.14% | 128 |
|
|
2024
Q4 | $238K | Buy |
2,579
+59
| +2% | +$5.45K | 0.12% | 154 |
|
|
2024
Q3 | $211K | Buy |
+2,520
| New | +$211K | 0.12% | 159 |
|
|
2021
Q2 | – | Sell |
-3,248
| Closed | -$212K | – | 207 |
|
|
2021
Q1 | $212K | Buy |
+3,248
| New | +$212K | 0.12% | 195 |
|
|
2016
Q3 | – | Sell |
-4,708
| Closed | -$392K | – | 128 |
|
|
2016
Q2 | $392K | Buy |
4,708
+1,053
| +29% | +$87.7K | 0.39% | 61 |
|
|
2016
Q1 | $338K | Buy |
3,655
+435
| +14% | +$40.2K | 0.39% | 66 |
|
|
2015
Q4 | $325K | Buy |
+3,220
| New | +$325K | 0.36% | 69 |
|
|
2015
Q3 | – | Sell |
-4,923
| Closed | -$576K | – | 100 |
|
|
2015
Q2 | $576K | Buy |
4,923
+1,072
| +28% | +$125K | 0.73% | 35 |
|
|
2015
Q1 | $378K | Buy |
3,851
+1,428
| +59% | +$140K | 0.43% | 61 |
|
|
2014
Q4 | $242K | Buy |
+2,423
| New | +$242K | 0.3% | 76 |
|